FEATURED COMPANIES
- Advansor A/S
- Clariant Ag
- Green & Cool
- Kemira Oyj
- Nalco an Ecloab Company
- Shecco Sprl
- MORE
Representing the developed world, the United States will maintain a 8.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$130.8 Million to the region's size and clout in the next 5 to 6 years. Over US$132.9 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Cardiovascular will reach a market size of US$206.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.9% over the next couple of years and add approximately US$489.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- Antares Pharma, Inc.
- Bayer AG
- Durect Corporation
- Iontera, Inc.
- Janssen Pharmaceuticals, Inc.
- Nitto Denko Corporation
- Novartis AG
- Pantec Biosolutions AG
- Tesa Labtec GmbH
- Teva Pharmaceutical Industries Ltd.
FEATURED COMPANIES
- Advansor A/S
- Clariant Ag
- Green & Cool
- Kemira Oyj
- Nalco an Ecloab Company
- Shecco Sprl
- MORE
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Transcritical CO2 Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Transdermal Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Transdermal Drug Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Transdermal Drug Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Cardiovascular (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
TABLE 5: Cardiovascular (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 6: Cardiovascular (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: CNS (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
TABLE 8: CNS (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
TABLE 9: CNS (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
TABLE 10: Dermatology (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
TABLE 11: Dermatology (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 12: Dermatology (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 14: Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
TABLE 15: Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Pain Management (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 17: Pain Management (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
TABLE 18: Pain Management (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Transcritical CO2 Systems Market Share (in %) by Company: 2019 & 2025
TABLE 19: United States Transdermal Drug Delivery Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 20: Transdermal Drug Delivery Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
TABLE 21: Transdermal Drug Delivery Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
TABLE 22: Canadian Transdermal Drug Delivery Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 23: Transdermal Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 24: Canadian Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
TABLE 25: Japanese Demand Estimates and Forecasts for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 26: Japanese Transdermal Drug Delivery Market in US$ Million by End-Use: 2009-2017
TABLE 27: Transdermal Drug Delivery Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
TABLE 28: Chinese Demand for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 29: Transdermal Drug Delivery Market Review in China in US$ Million by End-Use: 2009-2017
TABLE 30: Chinese Transdermal Drug Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Transcritical CO2 Systems Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 31: European Transdermal Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 32: Transdermal Drug Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 33: European Transdermal Drug Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 34: European Transdermal Drug Delivery Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 35: Transdermal Drug Delivery Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 36: European Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
TABLE 37: Transdermal Drug Delivery Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
TABLE 38: French Transdermal Drug Delivery Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 39: French Transdermal Drug Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
GERMANY
TABLE 40: Transdermal Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 41: German Transdermal Drug Delivery Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 42: Transdermal Drug Delivery Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
TABLE 43: Italian Demand for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 44: Transdermal Drug Delivery Market Review in Italy in US$ Million by End-Use: 2009-2017
TABLE 45: Italian Transdermal Drug Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 46: United Kingdom Demand Estimates and Forecasts for Transdermal Drug Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 47: United Kingdom Transdermal Drug Delivery Market in US$ Million by End-Use: 2009-2017
TABLE 48: Transdermal Drug Delivery Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 49: Rest of Europe Transdermal Drug Delivery Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 50: Transdermal Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 51: Rest of Europe Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 52: Transdermal Drug Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
TABLE 53: Asia-Pacific Transdermal Drug Delivery Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 54: Asia-Pacific Transdermal Drug Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
REST OF WORLD
TABLE 55: Rest of World Transdermal Drug Delivery Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 56: Transdermal Drug Delivery Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 57: Rest of World Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
IV. COMPETITION
ADVANSOR A/S
BITZER KÜHLMASCHINENBAU GMBH
BALTIMORE AIRCOIL COMPANY
CARNOT REFRIGERATION
CARRIER COMMERCIAL REFRIGERATION EUROPE
CLARIANT AG
DANFOSS GMBH
DOWDUPONT
EMERSON CLIMATE TECHNOLOGIES
GREEN & COOL
HALLIBURTON
HENRY TECHNOLOGIES
KEMIRA OYJ
LMP SYSTEMS INC.
MAYEKAWA MFG.
NALCO AN ECLOAB COMPANY
PARKER HANNIFIN CORPORATION
SCM FRIGO S.P.A
SCHLUMBERGER
SHECCO SPRL
STEPAN COMPANY
THE LUBRIZOL CORPORATION
V. CURATED RESEARCH
LOADING...
- Advansor A/S
- Bitzer Kühlmaschinenbau Gmbh
- Baltimore Aircoil Company
- Carnot Refrigeration
- Carrier Commercial Refrigeration Europe
- Clariant Ag
- Danfoss Gmbh
- Dowdupont
- Emerson Climate Technologies
- Green & Cool
- Halliburton
- Henry Technologies
- Kemira Oyj
- Lmp Systems Inc.
- Mayekawa Mfg.
- Nalco an Ecloab Company
- Parker Hannifin Corporation
- Scm Frigo S.P.A
- Schlumberger
- Shecco Sprl
- Stepan Company
- The Lubrizol Corporation
